Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Remimazolam Versus Propofol on Motor Evoked Potentials and Somatosensory Evoked Potentials During Spinal Tumor Surgery
NCT07901504Phase 4Not yet recruiting
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- Jan 2027
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in spinal cord neoplasm (SCT), spinal neoplasm, sponsored by Beijing Tsinghua Changgung Hospital. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
spinal cord neoplasm (SCT)spinal neoplasm
Beyond the preview
Go deeper on NCT07901504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07901504.